Inovio Pharma (INO), GeneOne Initiate Patient Recruitment for MERS Vaccine Trial

January 28, 2016 8:34 AM

Inovio Pharmaceuticals, Inc. (NASDAQ : INO) today announced the beginning of recruitment for its collaborative vaccine study for MERS (Middle ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found